RET and lung carcinoma: Further, they identified the KIF5B-RET fusion in two more cases out of 20 primary lung adenocarcinomas in the replication study demonstrating that a subset of NSCLCs could be caused by a fusion of KIF5B and RET, and suggesting the chimeric oncogene as a promising molecular target for the personalized diagnosis and treatment of lung cancer.